The Clinical and Forensic Toxicology of Z-drugs
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The Z-drugs zolpidem, zopiclone, and zaleplon were hailed as the innovative hypnotics of the new millennium, an improvement to traditional benzodiazepines in the management of insomnia. Increasing reports of adverse events including bizarre behavior and falls in the elderly have prompted calls for caution and regulation. Z-drugs have significant hypnotic effects by reducing sleep latency and improving sleep quality, though duration of sleep may not be significantly increased. Z-drugs exert their effects through increased γ-aminobutyric acid (GABA) transmission at the same GABA-type A receptor as benzodiazepines. Their pharmacokinetics approach those of the ideal hypnotic with rapid onset within 30 min and short half-life (1-7 h). Zopiclone with the longest duration of action has the greatest residual effect, similar to short-acting benzodiazepines. Neuropsychiatric adverse events have been reported with zolpidem including hallucinations, amnesia, and parasomnia. Poisoning with Z-drugs involves predominantly sedation and coma with supportive management being adequate in the majority. Flumazenil has been reported to reverse sedation from all three Z-drugs. Deaths from Z-drugs are rare and more likely to occur with polydrug overdose. Z-drugs can be detected in blood, urine, oral fluid, and postmortem specimens, predominantly with liquid chromatography-mass spectrometry techniques. Zolpidem and zaleplon exhibit significant postmortem redistribution. Zaleplon with its ultra-short half-life has been detected in few clinical or forensic cases possibly due to assay unavailability, low frequency of use, and short window of detection. Though Z-drugs have improved pharmacokinetic profiles, their adverse effects, neuropsychiatric sequelae, and incidence of poisoning and death may prove to be similar to older hypnotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence 3 9 38 suggests that pharmacodynamic factors—such as selectivity for specific GABA A receptor subunits—and pharmacokinetic parameters—such as half-life and absorption rate—play a crucial role in determining the risk of dependence, withdrawal, and adverse effects associated with these agents.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The comparatively low levels of zaleplon toxicity/fatalities here identified could, however, be associated with the molecule’s ultra-short half-life and rapid antemortem metabolism, which can affect its detection (Gunja, 2013).”
From An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions (2019) · cites this paper as Gunja, 2013
The cited source says what the claim attributes to it.
In the citing paper
“These differences are consistent with the mechanism of action and pharmacological properties of benzodiazepines and z-drugs.”
From Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health (2023) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“Z-drugs bind preferentially to GABAA receptors containing α1-subunits, which modulate sedation and amnesia (25, 26).”
From Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health (2023) · cites this paper as [25]
In the citing paper
“Benzodiazepines and z-drugs are positive allosteric modulators of the GABA-A receptor, producing their clinical effects by enhancing the effect of the neurotransmitter GABA at the GABA-A receptor (Cheng, Wallace, Ponteri, & Tuli, 2018; Gunja, 2013).”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Gunja, 2013
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disposition of Toxic Drugs and Chemicals in Man
Baselt, R. C. (1982) · Medical Entomology and Zoology · Cited by 1,813
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 1×
“Some studies quote that up to a third of elderly North Americans are prescribed either a Z-drug or benzodiazepine for sleep disturbance, an alarming statistic given the risks associated with hypnotics in the elderly [3].”
BackgroundDisposition of Toxic Drugs and Chemicals in Man
Christensen, H. (1983) · Forensic Science International · doi:10.1016/0379-0738(83)90025-7 · Cited by 565
Hajak, G., Müller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00491.x · Cited by 404 · cited 1×
“Tolerance, dependence, and withdrawal are all reported with Z-drugs, though this appears to be less severe and with lower incidence than for traditional benzodiazepines in the treatment of insomnia [5, 13, 40, 41].”
BackgroundPrinciples of Forensic Toxicology
(2020) · Springer eBooks · doi:10.1007/978-3-030-42917-1 · Cited by 385 · cited 2×
“Therapeutic maximal concentrations ( C max ) and those found in fatalities are shown in Table 4 [47, 51, 53, 55 – 62].”
Oral fluid testing for drugs of abuse
Bosker, W. M., & Huestis, M. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.108670 · Cited by 378 · cited 1×
“Risk of transmissible infection is much less than blood testing and there is evidence that oral fluid is more likely to show recent drug exposure [63].”
BackgroundZolpidem: A Review of Its Use in the Management of Insomnia
Swainston Harrison, T., & Keating, G. M. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00008 · Cited by 323
Holm, K. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00014 · Cited by 317
Greenblatt, D. J., & Roth, T. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.667074 · Cited by 283 · cited 2×
“Though abuse potential exists for all Z-drugs, it is more commonly reported for zolpidem and zopiclone [43, 45].”
BackgroundStewart, R., Besset, A., Bebbington, P., Brugha, T., Lindesay, J., Jenkins, R., Singleton, N., & Meltzer, H. (2006) · Sleep · doi:10.1093/sleep/29.11.1391 · Cited by 274 · cited 1×
“The rate of diagnosed insomnia in the UK and North America is estimated at 5–15%, with up to 40% of the population experiencing symptoms of daytime sleepiness [1, 2].”
BackgroundPotentially Harmful Drug–Drug Interactions in the Elderly: A Review
Hines, L. E., & Murphy, J. E. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.10.004 · Cited by 272 · cited 1×
“The combination of zolpidem and benzodiazepines has been shown to significantly increase the risk of hospitalization and hip fractures in the elderly [29].”
BackgroundScott-Ham, M., & Burton, F. C. (2005) · Journal of Clinical Forensic Medicine · doi:10.1016/j.jcfm.2005.03.009 · Cited by 251 · cited 1×
“In drug-facilitated crimes, where higher doses may have been administered, maximum recommended time intervals for Z-drug detection is 48 h in blood and 72 h in urine [54].”
Drover, D. R. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443040-00002 · Cited by 248 · cited 3×
“Pharmacokinetic properties of Z-drugs are shown in Table 1; major metabolic pathways are in italics [10, 12, 15–19].”
Victorri‐Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02861.x · Cited by 201 · cited 1×
“The potential for zolpidem abuse and dependence in insomniacs is being increasingly recognized with warnings on product labels appearing since 2004 [44].”
BackgroundResidual effects of sleep medication on driving ability
Verster, J. C., Veldhuijzen, D. S., & Volkerts, E. R. (2004) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.02.001 · Cited by 178 · cited 1×
“Type 1 (BZ 1 ) benzodiazepine receptors contain α 1 β 1-3 γ 2 subunits while BZ 2 subtypes contain α 2,3,5 β 1-3 γ 2 subunits [9].”
Hypnosedative-Induced Complex Behaviours: Incidence, Mechanisms and Management
Dolder, C. R., & Nelson, M. H. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00005 · Cited by 172
The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents
Sanger, D. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418001-00004 · Cited by 168 · cited 1×
“Tolerance, dependence, and withdrawal are all reported with Z-drugs, though this appears to be less severe and with lower incidence than for traditional benzodiazepines in the treatment of insomnia [5, 13, 40, 41].”
BackgroundSearching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics
Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163 · cited 3×
“Sedation and amnesia are mediated through the α 1 subunit, the most commonly distributed subunit throughout the brain, while those mediated via the α 2 and α 3 subunits appear to be involved in sleep regulation and anxiolysis [10].”
Non-benzodiazepines for the treatment of insomnia
Wagner, J., & Wagner, M. (2000) · Sleep Medicine Reviews · doi:10.1053/smrv.2000.0126 · Cited by 140 · cited 2×
“In general, Z-drugs are well tolerated and the most common adverse effects include headache, gastrointestinal upset, and dizziness [4, 6].”
BackgroundLaloup, M., Fernández, M. D. M. R., Boeck, G. D., Wood, M., Maes, V., & Samyn, N. (2005) · Journal of Analytical Toxicology · doi:10.1093/jat/29.7.616 · Cited by 134 · cited 1×
“Hair as a biological matrix has several advantages including ease of sampling, storage, and transportation [64].”
BackgroundClinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon
Hesse, L. M., Moltke, L. L., & Greenblatt, D. J. (2003) · CNS Drugs · doi:10.2165/00023210-200317070-00004 · Cited by 120 · cited 1×
“Clinically significant drug interactions of Z-drugs are shown in Table 2 [8, 18, 30 – 34].”
Post-mortem Toxicology: What The Dead Can And Cannot Tell Us: REVIEW
Leikin, J. B., & Watson, W. A. (2003) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-120018270 · Cited by 120 · cited 1×
“This postmortem redistribution (PMR) is observed for many drugs, including benzodiazepines [50].”
Najib, J. S. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.04.014 · Cited by 110
Evaluation of postmortem redistribution phenomena for commonly encountered drugs
Han, E., Kim, E., Hong, H., Jeong, S., Kim, J., In, S., Chung, H., & Lee, S. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.01.016 · Cited by 105 · cited 2×
“Both zolpidem and zaleplon exhibit significant PMR, though this seems to be low or negligible for zopiclone [48, 66 – 68].”
InfluentialScreening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS
Kintz, P., Villain, M., Concheiro, M., & Cirimele, V. (2005) · Forensic Science International · doi:10.1016/j.forsciint.2004.12.040 · Cited by 92 · cited 2×
“Techniques used in the analysis and detection of Z-drugs in various biological matrices are shown in Table 3 [46–52].”
MethodDrover, D., Lemmens, H., Naidu, S., Cevallos, W., Darwish, M., & Stanski, D. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)83043-x · Cited by 92 · cited 3×
“Therapeutic maximal concentrations ( C max ) and those found in fatalities are shown in Table 4 [47, 51, 53, 55 – 62].”
Use of Non-Benzodiazepine Hypnotics in the Elderly: Are All Agents the Same?
Dolder, C. R., Nelson, M., & McKinsey, J. (2007) · CNS Drugs · doi:10.2165/00023210-200721050-00003 · Cited by 82 · cited 3×
“Z-drugs have significant hypnotic effects by reducing sleep latency and improving sleep quality, though their ability to prolong total sleep time is debatable [4].”
Rust, K. Y., Baumgartner, M. R., Meggiolaro, N., & Kræmer, T. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.07.052 · Cited by 82 · cited 2×
“Techniques used in the analysis and detection of Z-drugs in various biological matrices are shown in Table 3 [46 – 52].”
Value of the concept of minimal detectable dosage in human hair
Kintz, P. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.10.018 · Cited by 80 · cited 1×
“Hair testing must be interpreted appropriately based on limits of detection, inability to determine dose ingested, and potential for poor drug uptake into hair at very low doses [65].”
BackgroundZolpidem-Associated Hallucinations and Serotonin Reuptake Inhibition: A Possible Interaction
Elko, C. J., Burgess, J. L., & Robertson, W. O. (1998) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563659809028939 · Cited by 80 · cited 1×
“Drug interactions be-tween zolpidem and various serotonergic and noradrenergic agents including SSRIs, venlafaxine, and tricyclic antidepressants have been reported to induce hallucinations [39].”
Acute Zolpidem Poisoning Analysis of 344 Cases
Garnier, R., Guerault, E., Muzard, D., Azoyan, P., Chaumet-Riffaud, A.-E., & Efthymiou, M.-L. (1994) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563659409011040 · Cited by 78 · cited 2×
“In the study by Garnier et al., 6 % of zolpidem overdose cases died; however, none were directly attributable to zol-pidem [56].”
InfluentialComa With Absent Brainstem Reflexes Resulting From Zolpidem Overdose
Kuźniar, T. J., Balagani, R., Radigan, K. A., Factor, P. H., & Mutlu, G. M. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318188bdca · Cited by 76
Toxicological investigations of drivers killed in road traffic accidents in Norway during 2006–2008
Gjerde, H., Christophersen, A. S., Normann, P. T., & Mørland, J. G. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.05.021 · Cited by 75
Role of Zolpidem in the Management of Insomnia
Dang, A., Garg, A., & Rataboli, P. V. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00158.x · Cited by 70 · cited 2×
“Currently, there are three Food and Drug Administration (FDA)-approved, commercially available, non-benzodiazepine drugs in the USA for the treatment of insomnia: zaleplon, zolpidem, and eszopi-clone (the active enantiomer of zopiclone) [5].”
George, C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06656-9 · Cited by 70 · cited 2×
“Zaleplon, though not appropriate for sleep maintenance therapy, may be taken for middle-of-the-night awakening [15].”
Zopiclone: is it a pharmacologic agent for abuse?
Cimolai, N. (2007) · PubMed Central · Cited by 69
Zopiclone poisoning: tissue distribution and potential for postmortem diffusion
Pounder, D. J., & Davies, J. I. (1994) · Forensic Science International · doi:10.1016/0379-0738(94)90273-9 · Cited by 67 · cited 1×
“Both zolpidem and zaleplon exhibit significant PMR, though this seems to be low or negligible for zopiclone [48, 66 – 68].”
Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement
Montplaisir, J. Y., Hawa, R., Moller, H. J., Morin, C. M., Fortin, M., Matte, J., Reinish, L. W., & Shapiro, C. M. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.445 · Cited by 62 · cited 2×
“The rate of diagnosed insomnia in the UK and North America is estimated at 5 – 15 %, with up to 40 % of the population experiencing symptoms of daytime sleepiness [1, 2].”
Changes in Fatalities Due to Overdose of Anxiolytic and Sedative Drugs in the UK (1983???1999)
Buckley, N. A., & McManus, P. R. (2004) · Drug Safety · doi:10.2165/00002018-200427020-00004 · Cited by 61
Greenblatt, D. J., Legangneux, E., Harmatz, J. S., Weinling, E., Freeman, J., Rice, K., & Zammit, G. K. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006293303 · Cited by 57 · cited 2×
“Pharmacokinetic properties of Z-drugs are shown in Table 1; major metabolic pathways are in italics [10, 12, 15–19].”
BackgroundPharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
Fernandez, C., Maradeix, V, Gimenez, F., Thuillier, A., & Farinotti, R. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08209-1 · Cited by 53 · cited 1×
“Eszopiclone ’ s onset is shorter and its offset more rapid than when the racemic mixture is administered to healthy volunteers [22, 23].”
Benefit-Risk Assessment of Zaleplon in the Treatment of Insomnia
Barbera, J., & Shapiro, C. (2005) · Drug Safety · doi:10.2165/00002018-200528040-00003 · Cited by 51 · cited 3×
“This leads to increased binding of GABA, a major inhibitory neurotransmitter in the central nervous system (CNS), to its own separate binding site and thereby increases the frequency of chloride channel opening [8].”
A Novel Clinical Pattern of Visual Hallucination After Zolpidem Use
Tsai, M., Huang, Y., & Wu, P. (2003) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120025354 · Cited by 49 · cited 1×
“Z-drug-induced neuropsychiatric adverse effects such as hallucinations and psychosis have been described for over 15 years, particularly with zolpidem [36 – 38].”
Acute Zolpidem Overdose--Report of Two Cases
Gock, S. B., Wong, S. H., Nuwayhid, N., Venuti, S. E., Kelley, P. D., Teggatz, J. R., & Jentzen, J. M. (1999) · Journal of Analytical Toxicology · doi:10.1093/jat/23.6.559 · Cited by 48 · cited 2×
“Therapeutic maximal concentrations (Cmax) and those found in fatalities are shown in Table 4 [47, 51, 53, 55–62].”
Comparison of the Fatal Toxicity Index of Zopiclone with Benzodiazepines
Reith, D. M., Fountain, J., McDowell, R., & Tilyard, M. (2003) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-120026520 · Cited by 45 · cited 1×
“However, a New Zealand study contra-dicted these findings showing that zopiclone had a similar FTI to commonly prescribed benzodiazepines [81].”
Two Cases of Fatal Zopiclone Overdose
Boniface, P. J., & Russell, S. G. G. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.2.131 · Cited by 37 · cited 2×
“Therapeutic maximal concentrations ( C max ) and those found in fatalities are shown in Table 4 [47, 51, 53, 55 – 62].”
Toxicology and Characteristics of Deaths Involving Zolpidem in New South Wales, Australia 2001–2010*
Darke, S. G., Deady, M., & Duflou, J. A. (2012) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2012.02117.x · Cited by 35
Drug interaction between St John’s wort and zolpidem in healthy subjects
Hojo, Y., Echizenya, M., Ohkubo, T., & Shimizu, T. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01223.x · Cited by 35 · cited 2×
“Clinically significant drug interactions of Z-drugs are shown in Table 2 [8, 18, 30–34].”
BackgroundMethodFlumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic
Patat, A. A., Naef, M. M., Gessel, É. V., Forster, A., Dubruc, C., & Rosenzweig, P. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.157 · Cited by 35 · cited 2×
“Flumazenil has been reported to antagonize the sedative effects of all three Z-drugs [24–27].”
BackgroundZosel, A. E., Osterberg, E. C., & Mycyk, M. B. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181d169ed · Cited by 33 · cited 1×
“In an American Poison Control Center study, zolpidem overdose was more likely to lead to intensive care admission when co-ingested with over-the-counter cold and flu preparations, other psychotropic medication, or ethanol [69].”
Zolpidem (Ambien): A Pediatric Case Series
Kurta, D. L., Myers, L. B., & Krenzelok, E. P. (1997) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659709001227 · Cited by 31 · cited 1×
“Pediatric cases of Z-drug ingestion have similarly demonstrated minimal toxicity in accidental poisoning [77].”
BackgroundBarkin, R. L. (2007) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31804c7292 · Cited by 30 · cited 2×
“Zolpidem is also available as an extended-release preparation (12.5 and 6.25 mg) intended for better management of sleep maintenance [11, 12].”
InfluentialZolpidem Distribution in Postmortem Cases
LEVINE, B. S., Wu, S.-C., & Smialek, J. E. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14465j · Cited by 25 · cited 1×
“Both zolpidem and zaleplon exhibit significant PMR, though this seems to be low or negligible for zopiclone [48, 66–68].”
BackgroundAcute zolpidem overdose leading to coma and respiratory failure
Hamad, A., & Sharma, N. (2001) · Intensive Care Medicine · doi:10.1007/s001340100972 · Cited by 25 · cited 1×
“Since then, reports of agitation, hallucinations, psychosis, and coma from Z-drug overdose have been published [70–73].”
BackgroundStaner, L., Eriksson, M. B., Cornette, F., Santoro, F., Muscat, N., Luthinger, R., & Roth, T. G. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.06.008 · Cited by 25
Halas, C. J. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050357 · Cited by 25
Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers
Vlase, L., Popa, A., Maria Adriana, N. E. A. G., Muntean, D. M., Bâldea, I., & Leucuta, S. E. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010383690 · Cited by 24 · cited 2×
“Clinically significant drug interactions of Z-drugs are shown in Table 2 [8, 18, 30–34].”
BackgroundMethodOlubodun, J. O. B., Ochs, H. R., Trüten, V., Klein, A., Moltke, L. L., Harmatz, J. S., Shader, R. I., & Greenblatt, D. J. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002237988 · Cited by 24 · cited 1×
“Smoking and oral contraceptive use have been studied in young women, with little effect on zolpidem kinetics [28].”
Dose-related illusions and hallucinations with zaleplon
Stone, J. R., Zorick, T. S., & TSUANG, J. W. (2008) · Clinical Toxicology · doi:10.1080/15563650701517442 · Cited by 22 · cited 1×
“Z-drug-induced neuropsychiatric adverse effects such as hallucinations and psychosis have been described for over 15 years, particularly with zolpidem [36–38].”
BackgroundNutt, D. J., & Feetam, C. L. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110374782 · Cited by 20 · cited 1×
“The addition of the R-enantiomer in racemic zopiclone may augment efficacy at the α 1 sub-unit and potentially lead to increased sedation and residual effects [14].”
Distribution of zolpidem in body fluids and organ tissues in five autopsy cases
Takayasu, T., Ishida, Y., Kimura, A., Kawaguchi, M., & Kondo, T. (2008) · Forensic Toxicology · doi:10.1007/s11419-008-0055-9 · Cited by 20 · cited 2×
“Therapeutic maximal concentrations (Cmax) and those found in fatalities are shown in Table 4 [47, 51, 53, 55–62].”
BackgroundJones, A. W., & Holmgren, A. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.05.008 · Cited by 19
Fatal Overdose of Zopiclone in an Elderly Woman with Bronchogenic Carcinoma
Bramness, J. G., Arnestad, M., Karinen, R., & Hilberg, T. (2001) · Journal of Forensic Sciences · doi:10.1520/jfs15131j · Cited by 18 · cited 2×
“Therapeutic maximal concentrations ( C max ) and those found in fatalities are shown in Table 4 [47, 51, 53, 55 – 62].”
Mixed drug intoxication involving zaleplon (“Sonata®”)
Moore, K. A., Zemrus, T. L., Ramcharitar, V., LEVINE, B. S., & Fowler, D. R. (2003) · Forensic Science International · doi:10.1016/s0379-0738(03)00130-0 · Cited by 18 · cited 1×
“Although there have been several reported fatalities where zaleplon has been ingested along with other drugs, none have been solely attributable to zaleplon [66, 82].”
BackgroundOlubodun, J. O. B., Ochs, H. R., Trüten, V., et al. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401382623 · Cited by 18
Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers
Vlase, L., Popa, A., Maria Adriana, N. E. A. G., Muntean, D. M., & Leucuta, S. E. (2010) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-010-0014-9 · Cited by 17 · cited 1×
“Clinically significant drug interactions of Z-drugs are shown in Table 2 [8, 18, 30 – 34].”
Two cases of methemoglobinemia following zopiclone ingestion
Fung, H. T., Lai, C. H., Wong, O. F., Lam, K. K., & Kam, C. W. (2008) · Clinical Toxicology · doi:10.1080/15563650701305558 · Cited by 14 · cited 1×
“Other unusual reports include hemolytic anemia and methemoglobinemia from zopiclone, suggesting oxidative stress from either the parent drug or its metabolites, one of which is an N -oxide derivative [74 – 76].”
Zaleplon-Induced Coma and Bluish Green Urine: Possible Antidotal Effect by Flumazenil
Höjer, J., Salmonson, H., & Sundin, P. (2002) · Journal of Toxicology Clinical Toxicology · doi:10.1080/07313810.2002.11863667 · Cited by 14 · cited 3×
“Flumazenil has been reported to antagonize the sedative effects of all three Z-drugs [24 – 27].”
Prolonged coma after eszopiclone overdose
Lovett, B., Watts, D. J., & Grossman, M. D. (2007) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2006.12.021 · Cited by 11 · cited 1×
“Since then, reports of agitation, hallucinations, psychosis, and coma from Z-drug overdose have been published [70 – 73].”
Louis, C. J., Fernández, B., Caminos, C. B., Pinillos, M. A., Bardom, A., & Encina, Y. (2008) · Clinical Toxicology · doi:10.1080/15563650701589417 · Cited by 11 · cited 1×
“Since then, reports of agitation, hallucinations, psychosis, and coma from Z-drug overdose have been published [70 – 73].”
New-Onset Transilent Hallucinations Possibly Due To Eszopiclone: A Case Study
Duggal, H. S. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0611e · Cited by 10 · cited 1×
“Z-drug-induced neuropsychiatric adverse effects such as hallucinations and psychosis have been described for over 15 years, particularly with zolpidem [36 – 38].”
Methods For The Analysis of Nonbenzodiazepine Hypnotic Drugs in Biological Matrices
Tonon, M. A., & Bonato, P. S. (2012) · Bioanalysis · doi:10.4155/bio.11.313 · Cited by 10 · cited 1×
“The principal mode of analysis remains gas or liquid chromatography with the detection method of choice being mass spectrometry, due to its rapid turnaround time and low limits of quantification [46].”
Anderson, D. T., & Budd, R. D. (2009) · Journal of Analytical Toxicology · doi:10.1093/jat/33.8.481 · Cited by 10 · cited 2×
“Both zolpidem and zaleplon exhibit significant PMR, though this seems to be low or negligible for zopiclone [48, 66 – 68].”
Zopiclone Overdose Responsive to Flumazenil
Cienki, J. J., Burkhart, K., & Donovan, J. W. (2005) · Clinical Toxicology · doi:10.1081/clt-200058944 · Cited by 9 · cited 2×
“Flumazenil has been reported to antagonize the sedative effects of all three Z-drugs [24 – 27].”
Zolpidem withdrawal delirium, seizure, and acute psychosis: Case reports and literature review
Chien, C.-C., Huanga, H.-T., Lung, F., & Lin, C. (2011) · Journal of Substance Use · doi:10.3109/14659890903013067 · Cited by 9 · cited 1×
“Withdrawal symptomatology resembles that from benzodiazepines, including insomnia, delirium, craving, anxiety, tremor, palpitations, and rarely, seizures and psychosis [42].”
BackgroundBrunello, N., Bettica, P. U., Amato, D., Maier, G. A., & Nutt, D. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70890-3 · Cited by 7 · cited 2×
“Eszopiclone ’ s onset is shorter and its offset more rapid than when the racemic mixture is administered to healthy volunteers [22, 23].”
Utility of flumazenil in zopiclone overdose
Yang, C., & Deng, J.-F. (2008) · Clinical Toxicology · doi:10.1080/15563650802043660 · Cited by 6
Hemolytic anemia after zopiclone overdose
Fung, H. T., Lai, C. H., Wong, O. F., Lam, S. K. T., & Lam, K. K. (2009) · Clinical Toxicology · doi:10.3109/15563650903313541 · Cited by 6 · cited 1×
“Other unusual reports include hemolytic anemia and methemoglobinemia from zopiclone, suggesting oxidative stress from either the parent drug or its metabolites, one of which is an N-oxide derivative [74–76].”
BackgroundZopiclone-associated methemoglobinemia and renal impairment
Kung, S., Tse, M. L., Chan, Y. C., Lau, F. L., Tsui, S. H., Tam, S., & Siu, T. S. (2008) · Clinical Toxicology · doi:10.1080/15563650802382175 · Cited by 6 · cited 1×
“Other unusual reports include hemolytic anemia and methemoglobinemia from zopiclone, suggesting oxidative stress from either the parent drug or its metabolites, one of which is an N -oxide derivative [74 – 76].”
Flumazenil dans les intoxications au zolpidem chez l'enfant
Carbajal, R., Blanc, P., Paupe, A., Lenclen, R., Hoenn, F., Olivier‐Martin, M., & Simon, N. (1996) · Archives de Pédiatrie · doi:10.1016/0929-693x(96)85081-0 · Cited by 4 · cited 1×
“Flumazenil has also been reported to reverse sedation within minutes in pediatric ingestions of zolpidem [78].”
Background
Cited by
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
“Z-drugs also cause cognitive impairments: case control studies find that BZD or Z-drug use approximately doubles the risk of being involved in a motor vehicle accident (Thomas, 1998; Gunja, 2013b).”
BackgroundBenzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis
Donnelly, K., Bracchi, R., Hewitt, J., Routledge, P. A., & Carter, B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174730 · Cited by 225
“Z-drugs were designed with a shorter elimination time (t1⁄2 = 1–7 hours) to act as a more clinically attractive alternative to BNZ [19].”
BackgroundSchifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz007 · Cited by 194
“Fatalities were here reported for all Z-drugs, although this typically occurred mostly with zolpidem and zopiclone, both typically ingested in a poly-drug misuse scenario, thus confirming previous reports (Garnier et al., 1994; Casula et al., 2013; Gunja, 2013).”
InfluentialHerbal medicine for insomnia: A systematic review and meta-analysis
Leach, M. J., & Page, A. T. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.12.003 · Cited by 184
In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving
Gunja, N. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0294-y · Cited by 177
Self-citation
Metadata
- Authors
- Gunja, N.
- Affiliations
- Children's Hospital at Westmead (AU)
- Corresponding author
- Gunja, Naren
- ORCID
- Gunja, Naren
- Venue
- Journal of Medical Toxicology
- Published
- 2013-02-13
- Volume
- 9
- Issue
- 2
- Pages
- 155-162
- ISSN
- 1556-9039 (ISSN-L)
- 1937-6995
- PMC
- PMC3657020
- OpenAlex
- W1990757549
- Cited by
- 230
- References
- 79
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 15 · 2023: 26 · 2022: 11 · 2021: 24 · 2020: 30 · 2019: 19 · 2018: 16 · 2017: 17 · 2016: 10 · 2015: 9 · 2014: 14 · 2013: 2
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Medical Toxicology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Historical and Scientific Studies
- Keywords
- Z-drugs, zolpidem, zopiclone, zaleplon, hypnotics, insomnia, GABAA receptor, pharmacokinetics, adverse events, postmortem redistribution, drug poisoning, flumazenil, forensic toxicology, drug detection, neuropsychiatric adverse effects
- MeSH terms
- Zolpidem, Acetamides, Coma, Flumazenil, Humans, Hypnotics and Sedatives, Piperazines, Pyridines, Pyrimidines, GABA Modulators, Azabicyclo Compounds, GABA-A Receptor Agonists, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.